Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/28937
Title: Home oxygen therapy.
Austin Authors: McDonald, Christine F 
Affiliation: Austin Health
Faculty of Medicine, University of Melbourne, Melbourne, Victoria, Australia..
Issue Date: Feb-2022
Date: 2022
Publication information: Australian prescriber 2022; 45(1): 21-24
Abstract: Long-term home oxygen therapy improves survival in patients with chronic obstructive pulmonary disease and persistent, severe hypoxaemia. It is uncertain that this benefit extends to patients with other chronic lung diseases. Oxygen is a treatment for hypoxaemia, not breathlessness. To confirm hypoxaemia, blood gas analysis is recommended before prescribing oxygen. There is limited and conflicting evidence that portable oxygen for exertional use is of benefit to patients with chronic obstructive pulmonary disease who do not have severe hypoxaemia. Laboratory studies show improvements in exercise capacity and dyspnoea, but these do not translate into significant benefits in the home setting. Patients should be educated regarding the expected benefits, risks and burdens of home oxygen therapy. It is particularly important that the patient does not smoke.
URI: https://ahro.austin.org.au/austinjspui/handle/1/28937
DOI: 10.18773/austprescr.2022.007
ORCID: 0000-0001-6481-3391
Journal: Australian prescriber
PubMed URL: 35233135
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/35233135/
ISSN: 0312-8008
Type: Journal Article
Subjects: blood gas analysis
chronic obstructive pulmonary disease
oxygen inhalation therapy
Appears in Collections:Journal articles

Show full item record

Page view(s)

22
checked on Jul 16, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.